Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Rocket Pharmaceuticals Q2 EPS $(0.83) Down From $(0.55) YoY

Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.83) per share. This is a 50.91 percent decrease over losses of $(0.55) per share from the same period last year.
byMichael Horton
August 8, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.83) per share. This is a 50.91 percent decrease over losses of $(0.55) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Preview: Employers Holdings’s Earnings

By Benzinga Insights
October 26, 1:29 PM
Employers Holdings (NYSE:EIG) is set to give its latest quarterly earnings report on Thursday, 2022-10-27. Here's what investors need to know before the announcement. Analysts estimate that Employers Holdings will report an earnings per share (EPS) of $0.44.

EIG

Read More

IMDb Helps Audiences Share And Discover Movie And TV Content With New TikTok Feature; Allows The TikTok Community To Link Movie And Tv Show Titles Within Their TikTok Videos And Showcase Their Favorite Titles Directly On Their Profiles

By Benzinga Newsdesk
January 5, 11:01 AM
The new feature, powered by IMDb data, allows the TikTok community to link movie and TV show titles within their TikTok videos and showcase their favorite titles directly on their profiles IMDb (www.imdb.com), the

AMZN

Read More

Inventiva Reports Q3 2023 Financial Information; Cash And Cash Equivalents At €43.8M, Short-Term Deposits At €0.03M, And Long-Term Deposit At €5M As Of September 30, 2023; Revenue For First 9 Months Amounted To €1.9M

By Benzinga Newsdesk
November 21, 5:02 PM
Cash and cash equivalents at €43.8 million, short-term deposits at €0.03 million2, and long-term deposit at €5.0 million3 as of September 30, 2023, compared to €86.7 million, €1.0 million and €0.7 million as of December

IVA